Nathan Campbell, a graduate student in the Experimental Therapeutics and Pharmacology program, will defend his dissertation, "The Role of AT1-AA in Causing Adult Hypertension in Offspring Born with Fetal Growth Restriction," at 11 a.m. on Friday, Dec. 1, in the Classroom Wing – CW 308. All Medical Center faculty, staff, and students are invited to attend.
